ProShares Ultra Nasdaq Biotechnology (BIB) Performance
BIB total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +38.4% since Dec 31, 2025
- 1 year
- +67.0% total return
- 5 years
- +4.9% a year
- 10 years
- +10.6% a year
- Since first price
- +17.8% a year since 2010
BIB trailing returns vs SPY, QQQ, AGG
| Period | BIB total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | −1.5% | −1.5% | −1.0% | −5.0% | +0.9% |
| 3 months | +11.5% | +11.4% | +3.2% | +1.9% | −0.4% |
| 6 months | +30.5% | +30.4% | +7.8% | +8.4% | −1.5% |
| YTD | +38.4% | +38.3% | +12.3% | +15.1% | −1.0% |
| 1 year | +67.0% | +66.6% | +14.4% | +15.9% | −1.1% |
| 3 years | +164.2%+38.2%/yr | +157.0% | +87.4%+23.3%/yr | +101.4%+26.3%/yr | +16.6%+5.2%/yr |
| 5 years | +27.3%+4.9%/yr | +23.8% | +79.3%+12.4%/yr | +94.0%+14.2%/yr | −0.8%−0.2%/yr |
| 10 years | +174.7%+10.6%/yr | +167.2% | +315.9%+15.3%/yr | +538.9%+20.4%/yr | +14.0%+1.3%/yr |
| 15 years | +1,390.0%+19.7%/yr | +1,349.0% | +696.0%+14.8%/yr | +1,299.3%+19.2%/yr | +32.2%+1.9%/yr |
| Since inceptionApr 8, 2010 | +1,412.9%+17.8%/yr | +1,368.7% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: BIB vs SPY
From Apr 8, 2010: BIB grew to $151,289, SPY to $85,597.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
BIB returns by calendar year
9 of 15 full years positive. Best 2013 (+159.6%), worst 2016 (−44.2%). 2026 is year to date.
BIB annual returns table
| Year | BIB | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +38.4% | −17.9% | +12.3% | +15.1% | −1.0% |
| 2025 | +59.2% | −36.4% | +17.7% | +20.8% | +7.2% |
| 2024 | −9.8% | −26.1% | +24.9% | +25.6% | +1.3% |
| 2023 | −1.1% | −35.0% | +26.2% | +54.9% | +5.7% |
| 2022 | −28.8% | −52.3% | −18.2% | −32.6% | −13.0% |
| 2021 | −6.0% | −33.3% | +28.7% | +27.4% | −1.8% |
| 2020 | +39.8% | −44.5% | +18.3% | +48.6% | +7.5% |
| 2019 | +46.7% | −31.5% | +31.2% | +39.0% | +8.5% |
| 2018 | −24.9% | −48.1% | −4.6% | −0.1% | +0.1% |
| 2017 | +40.5% | −20.3% | +21.7% | +32.7% | +3.6% |
| 2016 | −44.2% | −48.6% | +12.0% | +7.1% | +2.4% |
| 2015 | +13.9% | −48.8% | +1.2% | +9.4% | +0.5% |
| 2014 | +66.8% | −39.0% | +13.5% | +19.2% | +6.0% |
| 2013 | +159.6% | −20.3% | +32.3% | +36.6% | −2.0% |
| 2012 | +66.8% | −24.7% | +16.0% | +18.1% | +3.8% |
| 2011 | +15.6% | −41.4% | +1.9% | +3.4% | +7.7% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
BIB largest drawdowns
Now 12.5% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Jul 20, 2015 | −67.2% | Jun 27, 2016 | Jan 25, 2021 | 11 months | 5.5 years |
| Feb 8, 2021 | −66.2% | Apr 8, 2025 | Jul 7, 2026 | 4.2 years | 5.4 years |
| May 12, 2011 | −41.4% | Aug 8, 2011 | Jan 18, 2012 | 3 months | 8 months |
| Feb 25, 2014 | −39.0% | Apr 11, 2014 | Sep 24, 2014 | 45 days | 7 months |
| Apr 15, 2010 | −36.3% | Jul 1, 2010 | Dec 17, 2010 | 3 months | 8 months |
| Oct 5, 2012 | −24.7% | Nov 15, 2012 | Mar 1, 2013 | 41 days | 5 months |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
BIB risk statistics
| Statistic | 3 years | 5 years | 10 years | Since 2010 |
|---|---|---|---|---|
| Annualized return | +35.2% | +4.6% | +9.4% | +18.5% |
| Volatility (annualized) | 35.3% | 34.9% | 38.6% | 40.5% |
| Sharpe ratio | 0.91 | 0.20 | 0.36 | 0.59 |
| Sortino ratio | 1.76 | 0.31 | 0.58 | 0.95 |
| Best month | +25.9% | +25.9% | +30.7% | +30.7% |
| Worst month | −14.2% | −23.2% | −28.0% | −38.9% |
| Best 12 months | +121.0% | +121.0% | +121.0% | +201.3% |
| Worst 12 months | −23.2% | −49.8% | −51.8% | −57.0% |
| Positive months | 58% | 50% | 52% | 56% |
| Beta vs S&P 500 | 1.11 | 1.20 | 1.54 | — |
| Correlation with S&P 500 | 0.39 | 0.54 | 0.61 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
BIB rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 187 | −57.0% | +21.5% | +201.3% | 69% |
| 3-year (a year) | 163 | −17.0% | +7.4% | +97.9% | 68% |
| 5-year (a year) | 139 | −10.2% | +3.8% | +77.0% | 71% |
| 10-year (a year) | 79 | −6.8% | +9.4% | +30.2% | 87% |
Every holding period starting at a month-end since 2010. Returns for 3 years and longer are annualized.
BIB performance overview
ProShares Ultra Nasdaq Biotechnology (BIB) returned +67.0% over the past year and +10.6% a year over ten years, with distributions reinvested. Since its first recorded price in 2010 it has returned +17.8% a year, turning $10,000 into about $151,289. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −67.2%, from Jul 20, 2015 to Jun 27, 2016, and it took 4.6 years to get back to the old high. BIB finished 9 of its 15 full calendar years with a gain; the best year was 2013 (+159.6%) and the worst 2016 (−44.2%). Volatility has been 40.5% a year.
Related: BIB chart, BIB holdings, BIB dividends. See the BIB overview for the latest quote and fund facts.
BIB performance FAQ
What is the BIB return over the past year?
BIB returned +67.0% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 66.6%.
What is the average annual return of BIB?
BIB has returned +4.9% a year over 5 years, +10.6% a year over 10 years, +17.8% a year since April 8, 2010 (total return, distributions reinvested).
How much would $10,000 invested in BIB be worth?
$10,000 invested in BIB at its first recorded close on April 8, 2010 would be worth about $151,289 on October 23, 2026 with distributions reinvested.
What was the worst year for BIB?
The worst calendar year was 2016, with a total return of −44.2%. The best was 2013 at +159.6%.
What is the biggest drawdown of BIB?
The largest peak-to-trough decline was −67.2% between July 20, 2015 and June 27, 2016. It recovered to the old high on January 25, 2021, 4.6 years after the bottom.
How volatile is BIB?
Over the past 3 years BIB had an annualized volatility of 35.3% and a Sharpe ratio of 0.91 (excess return over 1–3 month T-bills per unit of risk).